Lv4
660 积分 2023-02-17 加入
Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet
3个月前
已完结
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
7个月前
已完结
[Research progress on pathogenic germline mutations in malignant tumors]
10个月前
已完结
Additivity predicts the efficacy of most approved combination therapies for advanced cancer
10个月前
已完结
Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT
11个月前
已完结
The evolving nosology of myeloid neoplasms: the semi-centennial of the 1976 French-American-British classification
11个月前
已完结
Measurable residual disease‐guided therapy in acute myeloid leukaemia: Practical insights
1年前
已完结
Measurable Residual Disease Monitoring in Acute Myeloid Leukaemia: Techniques, Timing and Therapeutic Implications
1年前
已完结
Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)
1年前
已完结
High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A
1年前
已关闭
皖公网安备34019202002308
